Megumi Inada‐Inoue

Phase I dose‐escalation study of buparlisib (<scp>BKM</scp>120), an oral pan‐class I <scp>PI</scp>3K inhibitor, in Japanese patients with advanced solid tumors

Megumi Inada‐Inoue, Ayako Mitsuma, Takayuki Yoshino et al. · Cancer Science · 2014 · 89 citations · Full text

Genetic polymorphisms associated with oxaliplatin-induced peripheral neurotoxicity in Japanese patients with colorectal cancer

Tomoyo Oguri, Ayako Mitsuma, Megumi Inada‐Inoue et al. · International Journal of Clinical Pharmacology and Therapeutics · 2013 · 37 citations

A phase I study of binimetinib (MEK162) in Japanese patients with advanced solid tumors

Koichiro Watanabe, Satoshi Otsu, Yoshinori Hirashima et al. · Cancer Chemotherapy and Pharmacology · 2016 · 35 citations

Tumor Biology, Oncology, Medicine +8

Association between bevacizumab-related hypertension and vascular endothelial growth factor (VEGF) gene polymorphisms in Japanese patients with metastatic colorectal cancer

Sachi Morita, Keisuke Uehara, Goro Nakayama et al. · Cancer Chemotherapy and Pharmacology · 2012 · 34 citations

Bevacizumab-related Hypertension, Medicine, Genetic Epidemiology +9

Association between severe toxicity of nilotinib and UGT1A1 polymorphisms in Japanese patients with chronic myelogenous leukemia

Takashi Shibata, Yosuke Minami, Ayako Mitsuma et al. · International Journal of Clinical Oncology · 2013 · 33 citations

Hematological Malignancy, Oncology, Medicine +9